PharmAthene is a biodefense company that develops medical countermeasures against biological and chemical threats. The company was formed to meet the needs of the U.S. and its allies. PharmAthene’s lead product development programs include an anthrax vaccine, treatment for anthrax infection, and a novel bioscavenger for the prevention and treatment of morbidity and mortality relating to chemical nerve agent exposure. For more information, visit the company’s Web site at www.PharmAthene.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: